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RESUMO 
 
O objetivo deste estudo foi avaliar a atividade anti-inflamatória e 
antinociceptiva do extrato etanólico de geoprópolis (EEGP) de Melipona scutellaris e 
frações químicas, bem como possíveis mecanismos de ação. Além disso, caracterizar 
quimicamente o EEGP e frações bioativas. Para avaliação da atividade anti-inflamatória 
foram aplicados os ensaios de recrutamento de neutrófilos na cavidade peritoneal, 
microscopia intravital e edema de pata induzido por carragenina. A via do óxido nítrico 
(NO) foi avaliada através da administração de inibidores desta via, além da avaliação da 
expressão das moléculas de adesão intercelular tipo 1 (ICAM-1) e quantificação de nitritos. 
A análise química do EEGP e fração bioativa foram realizadas pelos métodos de 
cromatografia gasosa com espectrometria de massas (CG/EM) e cromatografia líquida de 
alta eficiência em fase reversa (CLAE-FR). Para avaliação da atividade antinociceptiva, 
foram aplicados os ensaios de contorções abdominais induzida por ácido acético, teste da 
formalina, hipernocicepção inflamatória mecânica induzida por carragenina e quantificação 
das citocinas IL-1 β e TNF-α. A composição química do EEGP e frações bioativas foram 
avaliadas pela quantificação de fenóis e flavonóides totais. Conforme os resultados nos 
ensaios anti-inflamatórios, foi verificado que o EEGP e sua fração aquosa diminuíram a 
migração de neutrófilos na cavidade peritoneal induzido por carragenina, como também 
diminuíram a interação dos leucócitos (rolamento e adesão) com as células endoteliais. A 
administração de inibidores da via do NO suprimiu a atividade inibitória do EEGP e da 
fração aquosa sobre a migração de neutrófilos. A expressão de ICAM-1 apresentou-se 
diminuída, e os níveis de nitritos aumentados após o tratamento com EEGP e fração 
aquosa. No modelo de edema de pata induzido por carragenina, o EEGP e a fração aquosa 
apresentaram atividade anti-edematogênica. Nenhum padrão de ácido fenólico ou 
flavonóide, comumente encontrado em amostra de própolis de Apis mellifera, pôde ser 
detectado nas amostras de EEGP e da fração aquosa pelas técnicas de CG/EM e CLAE-FR. 
Nos ensaios de atividade antinociceptiva foi verificado que o EEGP e as frações hexânica e 
aquosa diminuíram o número de contorções abdominais induzida por ácido acético. No 
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teste da formalina, o EEGP e a fração aquosa inibiram ambas as fases (neurogênica e 
inflamatória), e a fração hexânica apenas a fase neurogênica. Foi evidenciada atividade do 
EEGP e fração aquosa na hipernocicepção inflamatória mecânica induzida por carragenina, 
como também foi constatado níveis diminuídos de IL-1β e TNF-α. Para as amostras de 
EEGP e frações hexânica e aquosa foi verificada a presença de compostos fenólicos e 
ausência de flavonóides. Estes resultados indicam que as frações bioativas encontradas 
possuem substâncias promissoras como novos agentes terapêuticos para o controle da 
inflamação e dor. 
 
Palavras chaves: Geoprópolis, Melipona scutellaris, anti-inflamatóro, antinociceptivo, 
óxido nítrico, citocinas. 
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ABSTRACT 
 
 
The aim of this study was to evaluate the anti-inflammatory and antinociceptive 
geopropolis of ethanolic extract (EEGP) of Melipona scutellaris and fractions, as well as a 
possible mechanism of actions. In addition, to characterize chemically EEGP and bioactive 
fractions. To evaluate the anti-inflammatory activity we used the recruitment of neutrophils 
into the peritoneal cavity, intravital microscopy and paw edema induced by carrageenan. 
The pathway of nitric oxide (NO) was demonstrated by administration of antagonists of this 
pathway, but also evaluated by the expression of intercellular adhesion molecule type 1 
(ICAM-1) and quantification of nitrites. Reversed-phase high-performance liquid 
chromatography (RP-HPLC) and gas chromatography/mass spectrometry (GC/MS) were 
used the phytochemical analyses. The tests used to evaluate the antinociceptive activity 
were abdominal contortions induced by acetic acid, formalin test, carrageenan-induced 
mechanical inflammatory hypernociception and quantification of IL-1 β and TNF-α. The 
quantification of total phenols and flavonoids was also determined in the EEGP and the 
bioactive fractions. In the anti-inflammatory tests the EEGP and the aqueous fraction 
decreased the neutrophil migration into the peritoneal cavity induced by carrageenan and 
also decreased the interaction of leukocytes (rolling and adhesion) with endothelial cells. 
The route of administration of inhibitors of NO abolished the inhibitory activity of the 
aqueous fraction and EEGP on neutrophil migration. The expression of ICAM-1 was 
reduced and nitrite levels increased after treatment with EEGP and aqueous fraction. In the 
paw edema induced by carrageenan, both EEGP and aqueous fraction showed anti-edema 
activity. No standards of flavonoid or phenolic acid commonly found in a sample of 
propolis of Apis mellifera could be detected in any samples of aqueous fraction or EEGP by 
GC/MS and RP-HPLC techniques. In tests to evaluate the antinociceptive activity was 
determined that EEGP, hexane and aqueous fractions decreased the number of abdominal 
constrictions induced by acetic acid. In the formalin test, the aqueous fraction and EEGP 
inhibited both phases (neurogenic and inflammatory), and the hexane fraction only 
neurogenic phase. The EEGP and the aqueous fraction showed activity in the carrageenan-
induced mechanical inflammatory hypernociception model, as also observed decreased 
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levels of IL-1β and TNF-α. The EEGP, hexane and aqueous fractions was verified the 
presence of phenolic compounds and absence of flavonoids. These results indicate that the 
bioactive fractions in the present study showed substances that could be promising new 
therapeutic agents to control inflammation and pain. 
 
Keywords: Geopropolis, Melipona scutellaris, anti-inflammatory, antinociceptive, nitric 
oxide, cytokines. 
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INTRODUÇÃO 
 
A resposta inflamatória é um conjunto de eventos que envolvem a participação 
de diferentes mediadores químicos capazes de promover vasodilatação, edema e a migração 
de leucócitos. Dentre estas alterações, podemos destacar a migração de leucócitos para o 
foco inflamatório como uma estratégia fundamental na defesa do organismo contra 
infecções (Malech & Gallin, 1987). 
Os neutrófilos são os principais leucócitos que participam na defesa do 
organismo durante o processo inflamatório (Mallech & Gallin, 1987). A migração destes 
leucócitos durante o processo inflamatório é decorrente da liberação de mediadores 
quimiotáxicos, como os mediadores lipídicos, citocinas e quimiocinas, que promovem o 
aumento da adesão dos neutrófilos com as células endoteliais (Mallech & Gallin, 1987; Dal 
secco et al., 2006). Este processo ocorre inicialmente, através do rolamento dos neutrófilos 
sobre o endotélio vênular, sendo este evento mediado por uma família de moléculas de 
adesão denominadas selectinas (L-, P- e E-selectinas). A seguir, ocorre uma forte adesão 
entre os neutrófilos e as células endoteliais, através das integrinas (β2-integrinas), que 
interagem com as imunoglubulinas, tais como as moléculas de adesão intercelular tipo 1  
(ICAM-1). Esta aderência permite, portanto, que os neutrófilos transmigrem para o foco 
inflamatório através das junções intercelulares (diapedese) presentes nas células endoteliais 
(Burke-Gaffney & Hellewell, 1996; Smith, 1993; Zhang et al., 2001; Pánes et al., 1999; 
Dinarello, 2000).  
No entanto, apesar de o recrutamento de neutrófilos ser uma resposta protetora 
do organismo, a ocorrência de uma resposta exacerbada gera efeitos indesejáveis o que 
pode levar a um progressivo dano tecidual no local inflamado, podendo este fenômeno 
ocorrer em diferentes doenças inflamatórias. Portanto, o bloqueio do tráfego de neutrófilos 
durante o processo inflamatório, vem sendo um alvo promissor na descoberta de novos 
fármacos anti-inflamatórios (Malech & Gallin, 1987).  
Aliado ao processo inflamatório, na maioria das situações ocorre o 
aparecimento de dor. Descrita como dor inflamatória, este evento é decorrente da liberação 
de mediadores inflamatórios, que provocam ativação e/ou sensibilização dos nociceptores. 
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No caso da sensibilização, ocorre uma diminuição do limiar de ativação do nociceptor, 
fazendo com o que o mesmo, seja ativado por estímulos que em condições normais seriam 
inócuos (Millan, 1999; Verri jr et al., 2006). 
Atualmente, as prostaglandinas são conhecidas como um dos principais 
mediadores responsáveis pela indução da dor inflamatória. Tal fato é compreensível, 
devido a ação analgésica dos anti-inflamatórios não esteróides (AINEs), que inibem a 
síntese de prostaglandinas, consequentemente diminuindo a dor inflamatória. No entanto, 
devido aos muitos efeitos adversos, como por exemplo, problemas renais e gástricos 
atribuídos ao uso prolongado dos AINEs, o controle da dor inflamatória ainda é um desafio 
(Verri jr et al., 2006). 
Dentre os recentes progressos dos estudos de dor inflamatória, destaca-se o 
papel das citocinas. Estudos têm mostrado que a liberação dos mediadores 
hipernociceptivos (como as prostaglandinas) durante o processo inflamatório, é decorrente 
de uma cascata de eventos iniciais, desencadeada por diferentes citocinas pró e anti-
inflamatórias. Devido a este achado, estas moléculas se tornaram alvos na descoberta de 
novos fármacos analgésicos (Verri jr et al., 2006; Cunha et al., 2005). 
Os produtos naturais, historicamente, levaram à descoberta de muitas drogas 
clinicamente úteis na terapêutica atual. De 1981 a 2002, 48 % dos novos fármacos 
descobertos, são de produtos naturais ou derivados dos mesmos (Newman et al., 2003). 
Estes dados mostram que os produtos naturais são uma fonte valiosa na descoberta de 
novos padrões moleculares bioativos, e os desafios dos pesquisadores, portanto, são 
identificar novas moléculas, elucidar o seu mecanismo de ação e propor o seu uso 
terapêutico (Barreiro; Viegas; Bolzani, 2006). 
A própolis um produto resinoso não tóxico coletado por abelhas tem sido 
relatada na literatura como possuidora de diversas atividades biológicas, incluindo anti-
inflamatória e antinociceptivo (Sforcin & Bankova, 2011; Paulino et al., 2003). Além disso, 
tem se demonstrado como uma fonte de recurso natural para a descoberta de novos 
compostos bioativos, como, por exemplo, o artepelim C (Ahn et al., 2007), apigenina e tt-
farnesol (Koo et al., 2003), CAPE (Sforcin & Bankova, 2011), dentre outros. 
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Por ser um produto obtido a partir de diferentes fontes vegetais, os constituintes 
químicos e atividades farmacológicas da própolis variam de acordo com a época do ano, 
tipo de vegetação existente em cada região onde é produzida e a espécie de abelha 
responsável pela coleta (Kӧnig, 1985; Greenaway et al., 1990; Park et al., 2002). Devido a 
estas características, cada vez mais estudos com diferentes variedades de própolis estão 
sendo realizados com o objetivo de isolamento e identificação de compostos bioativos que 
possam ser aplicados como novos agentes terapêuticos (Sforcin & Bankova, 2011). No 
entanto, a maioria dos estudos científicos se refere à própolis coletadas por abelhas Apis 
mellifera (Sforcin & Bankova, 2011), enquanto que outros tipos de própolis, coletadas por 
outras abelhas permanecem ainda sem descrição detalhada sobre as suas atividades 
biológica e características químicas. 
A geoprópolis uma mistura de resina, cera e terra, é uma própolis não comum, 
sendo coletada por abelhas nativas sem ferrão da tribo Meliponini, amplamente encontradas 
nas áreas tropicais e subtropicais do mundo todo (Nates-Parra, 2001; Barth, 2006; Roubem, 
1989; Cortopassi-Laurino et al., 2006).  
Dentre os poucos estudos com este tipo de própolis, Velikova et al. (2000) 
analisaram 21 amostras de geoprópolis de doze diferentes espécies de Meliponinae, e 
evidenciaram significativa atividade contra Staphylococcus aureus, além de atividade 
citotóxica. As mesmas amostras foram caracterizadas quimicamente, onde foi observada a 
presença de compostos como di e triterpenos e ácido gálico. Em outro estudo, Bankova et 
al. (1998) identificaram mais de cinquenta compostos, principalmente fenólicos e 
terpênicos em geoprópolis brasileira, produzida pelas abelhas Melipona compressipes, 
Melipona quadrifasciata anthidioides e Tetragona clavipes. 
A geoprópolis proveniente da espécie de abelha Melipona scutellaris, também 
conhecida popularmente como “uruçu” e encontrada no Nordeste do Brasil, tem sido alvo 
de interesse pelo nosso grupo de pesquisa. Estudos prévios constataram atividades 
biológicas, como antimicrobiana contra Staphylococcus aureus e antioxidante. Estes 
resultados sugerem, portanto, que mais estudos sejam realizados para identificação de 
outras atividades biológicas para este tipo de própolis (anti-inflamatória e antinociceptiva), 
como também a identificação de substâncias químicas novas que apresentem potencial 
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farmacológico promissor, propiciando a geoprópolis de Melipona scutellaris valorização 
cientifica, podendo tornar-se uma fonte de subsistência para comunidades carentes que 
dependem de sua produção.  
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Abstract 
 
The extensive neutrophil migration and tissue damage that accompanies it, are present in 
several inflammatory diseases. Therefore, the search for drugs that interfere with the traffic 
of neutrophils in the inflammatory process has been increasing. The aim of this study was 
to evaluate the activity of the ethanolic extract of geopropolis (EEGP) of Melipona 
scutellaris and its fractions on the modulation of neutrophil migration in the inflammatory 
process, as well as the participation of nitric oxide (NO) pathway, and to check the 
chemical profile of EEGP and the bioactive fraction. EEGP and its aqueous fraction 
decreased the neutrophil migration in the peritoneal cavity induced by carrageenan. In 
addition, leukocyte interaction (rolling and adhesion) with the endothelial cells decreased, 
which was evidenced by intravital miscroscopy. It was found that the injection of 
antagonists of NO pathway abolished the EEGP and the aqueous fraction inhibitory activity 
on the neutrophil migration. The expression of intracellular adhesion molecule type 1 
(ICAM-1) was reduced, and nitrite levels increased after treatment with EEGP and aqueous 
fraction. In the model of paw edema induced by carrageenan, EEGP and the aqueous 
fraction showed anti-edema activity. No pattern of flavonoid and phenolic acid commonly 
found in propolis samples of Apis mellifera could be detected in EEGP and aqueous 
fraction samples. According to the results, we conclude that the EEGP and the aqueous 
fraction showed inhibitory activity on the neutrophils influx in the inflammatory process 
and this effect could be related with the NO pathway. These data indicate that the aqueous 
fraction found has promising bioactive substances for anti-inflammatory activity. 
 
Keywords: Geopropolis; Melipona scutellaris; bioactive fraction; neutrophils; anti-
inflamatory; nitric oxide.  
 
 
____________________________ 
Abbreviations: AG, aminoguanidine; cGMP, guanosine 3′5′-cyclic monophosphate; DMSO, dimethyl 
sulphoxide; EEGP, ethanolic extract of geopropolis; GC-MS, gas chromatography/mass spectrometry; HPLC-
FR, high performance liquid chromatography reverse phase; ICAM-1 – intracellular adhesion molecule type 
1; iNOS, inducible nitric oxide synthase; NO, nitric oxide; NOS, nitric oxide synthases; sGC, soluble 
guanylate cyclase; ODQ, [1H-(1,2,4)oxadiazolo (4,3-a) quinoxalin-1-one]. 
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1. Introduction 
 
Neutrophils are the main leukocytes that participate in the defence of the body 
during the inflammatory process [1]. The process of neutrophil rolling and adhesion in 
endothelial cells, followed by its transmigration to the extravascular space, occurs due to 
the release of various chemical mediators such as cytokines, chemokines, and eicosanoids, 
which activate selectins, integrins, and immunoglobulin, respectively [2-6]. Although it has 
a protective effect, the intense neutrophil migration is related to tissue damage in several 
inflammatory diseases [1]. 
Many new drugs aim to interfere with the traffic of neutrophils in the 
inflammatory process, antagonizing cytokines, chemokines, integrins, selectins or 
immunoglobulin involved in this process, or even stimulating chemical mediators that 
inhibit the neutrophil migration [7-11]. 
Natural products have been researched for decades as a promising source in the 
discovery of new drugs, and Apis mellifera bee propolis has been reported in the literature 
as possessing various biological activities [12,13]. In addition, Apis mellifera propolis has 
been demonstrated as a source of natural resource for the discovery of new bioactive 
compounds, such as artepelim C [14], apigenin and tt-farnesol [15], CAPE [13], among 
others.  
Since it is a product obtained from different plant sources, the chemical 
constituents and pharmacological activities of propolis vary according to the time of year, 
existing vegetation type in each region where it is produced, and bee species responsible for 
collecting bee [16-18]. Due to these characteristics, several studies with propolis are 
performed to isolate and identify the new chemical compounds, which exhibit promising 
pharmacological potential and that can be applied as new therapeutic agents [13]. 
The geopropolis, a mixture of resin, wax and soil, is an uncommon propolis 
collected by native stingless bees of the Meliponini tribe and widely found in tropical and 
subtropical areas worldwide [19-21]. Among the geopropolis, the one from the bee 
Melipona scutellaris bee species has been the target of interest of our research group. 
Previous studies with geopropolis observed significant antimicrobial activity against 
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Staphylococcus aureus and also an antioxidant activity, suggesting thus that should be 
conducted more studies to identify other biological activities as well as the elucidation of its 
chemical profile, with the aim of identifying promisiong chemicals with pharmacological 
potential. 
Thus, the aim of this study was to evaluate the activity of the ethanolic extract 
of geopropolis (EEGP) of Melipona scutellaris and its fractions on the modulation of 
neutrophil migration in the inflammatory process, as well as the participation of NO 
pathway, and to check the chemical profile of EEGP and the bioactive fraction. 
 
2. Material and Methods  
 
2.1. Geopropolis samples and fractionation 
The geopropolis samples were collected from the inner parts of the beehives, 
more specifically in the space between the cover and supers of hives. Geopropolis was 
collected between June and July of 2010 in the seaside region, municipality of “Entre Rios” 
(SL 11°56'31'' and WL 38º05'04''), state of Bahia, Northeast of Brazil. The geopropolis 
(100 g) was extracted with absolute ethanol (w/v) of proportion (1/7), at 70 ºC, for 30 min, 
and then filtered to obtain the EEGP. The EEGP was further fractioned using a liquid–
liquid extraction technique with hexane, chloroform, and ethyl acetate solvents. At the end 
of three partitions, it was obtained a residue called „aqueous fraction‟. The fractions 
obtained were monitored by thin layer chromatography (TLC) using the anisaldehyde 
reagent (4-methoxy-benzaldehyde, acetic acid, sulphuric acid/1.0:48.5:0.5) and followed by 
incubation at 100 ºC for 5 min. Fluorescent substances were visualized under UV light at 
the wavelengths of 254 and 366 nm [22]. The EEGP and its hexane, chloroform, ethyl 
acetate, and aqueous fractions were concentrated in a rotaevaporator at 40 ºC to obtain a 
yield of 4.33 (w/w), 1.98 (w/w), 0.23 (w/w), 0.87 (w/w), and 1.25 (w/w), respectively. The 
extract and fractions were dissolved in DMSO, PBS 1 mM 1:99 for subcutaneous (s.c.) 
administration. 
 
2.2. Animals 
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Male SPF (specific-pathogen free) Balb/c mice weighing 20-25 g were housed 
in temperature of 22-25 °C, with a light cycle of 12 h light/ 12 h dark, humidity of 40-60 %, 
and with access to water and food ad libitum. All procedures were performed in accordance 
with the Guiding Principles in the Care and Use of Animals and approved by the local 
animal Ethics committee (CEUA UNICAMP process number 2037-1). 
 
2.3. Drugs and reagents 
Carrageenan, aminoguanidine (AG), [1H-(1,2,4)oxadiazolo (4,3-a) quinoxalin-
1-one] (ODQ) and dimethylsulphoxide (DMSO) were obtained from Sigma® Chemical 
Co., St. Louis, MO, USA, Indomethacin (MP Biomedicals®) and organic solvents from 
Merck®. 
 
2.4. Biological protocols 
 
2.4.1. Activity evaluation of EEGP and its fraction on the neutrophil migration in the 
peritoneal cavity induced by carrageenan. 
The mice were pretreated with EEGP, hexane, chloroform, ethyl acetate or 
aqueous fractions (1, 3, 10 and 30 mg, s.c.). Vehicle was used as negative control. After 30 
min of treatment, it was applied carrageenan i.p. at a dose of 500 µg/cavity. After 4 h, the 
animals were dead and the peritoneal cavity washed with 3 mL of PBS/EDTA (1 mM). For 
total cell count, it was utilized the Newbauer chamber, and for differential count, performed 
by preparing smears in a cytocentrifuge (citospin; Shandon Lipshaw Inc, Pittsburgh, 
Pennsylvania, USA), which were stained with fast panotic kit, and for differentiated cells 
(100 cells total), a optical microscope (1000x increase) was utilized. The results were 
expressed as the number of neutrophils per cavity. 
 
2.4.2. Evaluation of EEGP activity and bioactive fraction selected on the rolling and 
adhesion of leukocytes in the mesenteric microcirculation by intravital microscopy 
The mice were pretreated with EEGP or aqueous fraction (10 mg/kg, s.c.) 30 
min before the i.p. injection of carrageenan 500 µg/cavity. The negative control group 
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received the vehicle. After 2 and 4 h of the inflammatory stimulus, the rolling and adhesion 
of neutrophils were rated as previously described [23,24]. The animals were anesthetized, 
and the mesenteric tissue was exposed to in-situ assessment by intravital microscopy. The 
animals were placed on a plate with a thermostat at 37 °C, where the mesenteric tissue was 
kept warm and moist with Ringer Locke solution (pH 7.2 to 7.4) containing 1 % of gelatin. 
The post-capillary venules, which had a diameter of 10-18 μm, were chosen, and the 
interaction of leukocytes with the luminal surface of the endothelium venule was assessed, 
where we counted the number of rolling leukocytes for 10 min. Leukocytes were 
considered adherent to the endothelium if they remained stationary for >30 s. Cells were 
counted, and the image was recorded using five different fields for each animal to avoid 
variability due to sampling. Calculations were made for each animal. 
 
2.4.3. Effect of inhibitors of NO pathway on the EEGP inhibitory effect and bioactive 
fraction selected on the neutrophil migration in the peritoneal cavity induced by 
carrageenan. 
The animals were pretreated with a selective inhibitor of iNOS 
(aminoguanidine 50 mg/kg, s.c.), or a selective inhibitor of soluble guanylate cyclase (ODQ 
5μmol / kg, i.p.) 30 min before EEGP or aqueous fraction (10 mg/kg, s.c.) administration. 
The negative control group received the vehicle. After 30 min of treatment, it was applied 
carrageenan at a dose of 500 µg/cavity and the neutrophil migration was determined as 
described in Section 2.4.1. 
 
2.4.4. Evaluation of ICAM-1 expression by Western blot against the EEGP treatment and 
the bioactive fraction in mice subjected to injection of carrageenan in the peritoneal cavity 
The mice were pretreated with EEGP or aqueous fraction (10 mg/kg, s.c.). The 
negative control group received the vehicle. After 30 min of treatment, it was applied 
carrageenan i.p. at a dose of 500 µg/cavity. After 4 h, the animals were dead, then the 
mesenteric tissue was dissected, and the proteins were isolated. Tissues were lysed in 400 
mL of buffer (1 % Triton X-100, 1 M NaF, 100 mM Nappi, 1M Na3VO4, 1 mg/ml 
aprotinin, 1 mg/ml leupeptin , 1 mg/ml PMSF) and centrifuged at 4 °C for 20 min at 
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12.300/g. Equal amounts of protein (50 µg) were separated by 10 % SDS-PAGE and 
transferred to a nitrocellulose membrane (Bio-Rad). The standard molecular weight (Bio-
Rad) was run in parallel to estimate the molecular weight. Membranes were blocked, 
overnight at 4 °C, in TBS-T (20 mM Tris-HCl (pH 7.5), 500 mM NaCl, 0.1 % Tween 20) 
plus 5 % of non-fat skim milk powder. After the blocking, the membranes were incubated, 
overnight at 4 ° C, with rabbit anti-ICAM-1 (1:200) or α-tubulin (Santa Cruz 
Biotechnology), utilized as an internal control (1:1000) diluted in TBS-T containing 5 % of 
non-fat skim milk powder. The membranes were then incubated with rabbit anti-IgG 
conjugated to peroxidase (1/2000) diluted in TBS-T containing 5 % of non-fat milk powder 
at room temperature for 30 min. Finally, the bands recognized by the specific antibody 
were visualized using a chemiluminescence-based ECL system (Amersham Biosciences) 
and exposed to an x-ray film for 30 min (Eastman Kodak). A computer imaging system 
(Gel-Pro Analyzer) was utilized to measure the intensity of the OD of the bands. 
 
2.4.5. Evaluation of nitrite levels for EEGP treatment and bioactive fraction in mice 
subjected to injection into the peritoneal cavity of carrageenan 
The mice were pretreated with EEGP or aqueous fraction (10 mg/kg, s.c.). The 
negative control group received the vehicle. After 30 min of treatment, it was applied 
carrageenan i.p. at a dose of 500 µg/cavity. After 4 h, the animals were dead and the 
peritoneal cavity washed with 3 mL of PBS/EDTA (1 mM). The production of NO was 
determined in the peritoneal lavage using the Griees method [25] by measuring the nitrite 
concentration in an ELISA plate at 540 nm, and the results were expressed in micromoles 
of nitrite. 
 
2.4.6. Evaluation of EEGP activity and bioactive fraction selected on the paw edema 
induced by carrageenan 
The mice were pretreated with EEGP or aqueous fraction (1, 3, 10, and 30 
mg/kg, i.p.). Indomethacin (10 mg/kg, s.c.) was used as positive control, and vehicle as 
negative control. After 30 min of treatment, the animals were subjected to an intraplantar 
injection of 50 µL carrageenan (1mg/paw) in the left hind leg. The animal's paw volume 
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was measured before (time 0) and after injection of carrageenan (1, 2, 3, 4, and 5 h) 
utilizing a plethysmometer (Ugo Basile, model 7150, Italy). The results were expressed as 
the threshold of the inflamed paw Δ (mL), which was calculated by subtracting the values 
obtained before (time 0) and after the injection of carrageenan [26]. 
 
2.5. Chemical analysis of EEGP and bioactive fraction 
 
2.5.1. Gas chromatography with mass spectrometry 
About 15 mg of EEGP and aqueous fraction were mixed with 100 μL of N-
methyl-N-trimethylsilyltrifluoroacetamide (MSTFA) in a sealed glass tube for 15 min at 60 
°C to form TMS derivatives before analyzing with gas chromatography/mass spectrometry 
(GC-MS). After that time, the reagent's derivation was removed under nitrogen flow, and 
the product of the reaction was diluted again in hexane (600 μL), according to the method 
described by [27] with some modifications. Shimadzu gas chromatograph, model 2010 GC, 
coupled to mass spectrometer Shimadzu, model QP 2010 Plus, were employed for all 
analyses. Samples were separated on a capillary column (RTX5MS 30 m x 0.25 mm x 0.25 
μm). The column temperature was initially held at 80 °C for 1 min, and then the 
temperature was raised to 320 °C at a rate of 20 °C min
-1
, followed by an isothermal period 
of 20 min. The total run time was 69 min. Ultra-high-purity helium with an inline oxygen 
trap was used as carrier gas. The injector was heated to 280 °C and was on split mode with 
a split ratio of 1:20, and the injection volume was 0.4 μL. The integration was done in the 
software solution LabSolutions-GCMS, and the identification of detected compounds was 
performed by comparison with the data of mass spectra libraries Wiley8. The compounds 
that were not identified, characterized the principal molecular ions, according to the mass-
charge ratio (m/z). 
 
2.5.2. High performance liquid chromatography reverse phase 
Ten microliters of each sample (EEGP or aqueous fraction) were injected into a 
liquid chromatograph coupled to a photodiode array detector at 260 nm, and the samples 
were eluted through a C18 reverse phase column (250 x 4.6 mm), with particle size of 5 
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μm. The mobile phase was water/acetic acid (19:1, v/v) (solvent A) and methanol (solvent 
B) with constant rate of 1 mL/min. The gradient started with 30 % of solvent B to 40 % of 
B in 15 min, 50 % of B in 30 min, 60 % of B in 45 min, 75 % of B in 65 min, 75 % of B in 
85 min, 90 % of B in 95 min, 90 % of B in 110 min and 30 % of B in 120 min. The column 
was maintained at a constant temperature of 350 °C [28]. For the aqueous fraction, it was 
also utilized another mobile phase composed of water/acetic acid (98/2) (solvent A) and 
water/acetonitrile/acetic acid (68/30/2) with constant rate of 1 mL/min. The gradient started 
with 0 to 30 % of solvent B in 20 min, 30 to 50 % of B in 10 min, 50 to 70 % of B in 20 
min, 70 to 100 % of B in 5 min, 100 % of B in 20 min, 100 to 0 % of B in 10 min [29]. We 
utilized authentic standards of flavonoids and phenolic acids to compare the retention time 
of substances in EEGP and aqueous fraction samples.  
 
2.6. Statistical analysis 
Data were expressed as mean ± standard error of the mean (SEM), and 
statistical comparison between groups were made utilizing analysis of variance (ANOVA) 
followed by Tukey test. Significance was accepted when p ≤ 0.05. 
 
3. Results 
 
3.1. EEGP and aqueous fraction inhibit the neutrophil migration in the peritoneal cavity  
We evaluated the activity of EEGP and its aqueous fraction on the neutrophil 
migration in the peritoneal cavity induced by carrageenan. Regarding the results, it was 
found that administration of EEGP decreased the influx of neutrophils into the peritoneal 
cavity, compared to the carrageenan group (p <0.05), where there was a reduction of 41, 
61, 62, and 50 % for doses 1, 3, 10, and 30 mg/kg (Figure 1A), respectively. With regard to 
the chemical fractions studied, the hexane fraction (Figure 1B), the chloroform fraction 
(Figure 1C), and the ethyl acetate fraction (Figure 1D) showed no significant inhibition of 
neutrophil recruitment (p> 0.05). On the other hand, the aqueous fraction decreased the 
number of neutrophils in the peritoneal cavity after injection of carrageenan (p <0.05), 
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where we observed an inhibition of 66 and 64 % for doses of 10 and 30 mg/kg, respectively 
(Figure 1E). Thus, the aqueous fraction was selected as the bioactive fraction of EEGP.  
 
Figure 1. Inhibitory effect of ethanolic extract of geopropolis (EEGP) and aqueous fraction (AF) on the 
neutrophils migration into the peritoneal cavity induced by carrageenan. The neutrophil migration was 
determined 4 h after the injection of carrageenan 500 μg/cavity. Mice previously treated with vehicle (saline 
and carrageenan), EEGP (A), hexane fraction (FH-B), chloroform (FC-C), ethyl acetate (EAF-D), or aqueous 
(AF-E). The data are expressed by mean ± SEM, n = 6. Symbols indicate statistical difference (p <0.05, 
Tukey test). # compared to the saline group; * compared to the carrageenan group. 
 
3.2. EEGP and aqueous fraction inhibit the rolling and adhesion of leukocytes induced  
By checking the activity on the reduction of the neutrophil migration in the 
peritoneal cavity, we evaluated the activity of EEGP and aqueous fraction on the rolling 
and adhesion of leukocytes to endothelial cells. Based on the results, we found that EEGP 
and the aqueous fraction, at a dose of 10 mg/kg, decreased leukocyte rolling and adhesion 
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on endothelial cells, compared to the carrageenan group (p <0.05), with an inhibition of 48 
and 58 % to the rolling (Figure 2A), and 75 and 61 % for the adhesion of leukocytes 
(Figure 2B), respectively.  
 
Figure 2. Inhibitory effect of ethanolic extract of geopropolis (EEGP) and aqueous fraction (AF) on the 
rolling (A) and adhesion (B) of leukocytes assessed by intravital microscopy in mesenteric tissue of mice, 2 
and 4 h after i.p. injection of carrageenan 500 µg/cavity. Mice were pretreated with vehicle (saline and 
carrageenan), EEGP, or aqueous fraction (10 mg/kg). The data are expressed by mean ± SEM, n = 5. Symbols 
indicate statistical difference (p <0.05, Tukey test). # compared to the saline group; * compared to the 
carrageenan group. 
 
3.3. Inhibitors of NO pathway cause suppression on the EEGP inhibitory effect and 
aqueous fraction on the neutrophil migration induced by carrageenan 
In order to elucidate the mechanism of action by which EEGP and aqueous 
fraction inhibit the neutrophil migration, we initially studied their action in the NO 
pathway. According to the results, we observed that the application of antagonists of NO 
pathway (Figure 3A, and B) abolished the inhibitory effect of EEGP and aqueous fraction, 
at a dose of 10 mg/kg, on the neutrophil migration induced by carrageenan (p <0.05), thus 
confirming that the inhibitory action of recruitment of neutrophils is at least partly due to 
the NO pathway. 
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Figure 3. Inhibitory effect of ethanolic extract of geopropolis (EEGP) and aqueous fraction (AF) on the 
neutrophils migration into the peritoneal cavity induced by carrageenan. The neutrophil migration was 
determined 4 h after the injection of carrageenan 500 μg/cavity. Mice were pretreated with aminoguanidine 
(AG - 50 mg/kg, A), and ODQ (5μmol/kg, B) antagonists. After 30 min, the animals were pretreated with 
vehicle (saline and carrageenan), EEGP, or aqueous fraction (10 mg/kg). The data are expressed by mean ± 
SEM, n = 6. Symbols indicate statistical difference (p<0.05, Tukey test). # compared to the saline group; * 
compared to the carrageenan group; ** compared to the groups that received only EEGP and the aqueous 
fraction. 
 
3.4. EEGP and aqueous fraction decrease the expression of ICAM-1 and increase nitrite 
levels in mice subjected to injection of carrageenan in the peritoneal cavity 
Regarding the expression of adhesion molecules ICAM-1, we observed that 
treatment with EEGP and aqueous fraction, at a dose of 10 mg/kg, reduced its expression (p 
<0.05) when compared to the carrageenan group (Figure 4A). Besides, the treatment with 
EEGP and aqueous fraction (10 mg/kg) increased the nitrite levels (p <0.05) when 
compared to the carrageenan group (Figure 4B). 
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Figure 4.  Effect of ethanolic extract of geopropolis (EEGP) and aqueous fraction (AF) on the expression of 
ICAM-1 (A) and NO levels (B) 4 h after the injection of 500 μg/cavity of carrageenan in the peritoneal cavity. 
Mice were pretreated with vehicle (saline and carrageenan), EEGP, or aqueous fraction (10 mg/kg, s.c.). The 
data are expressed by mean ± SEM, n = 5. Symbols indicate statistical difference (p <0.05, Tukey test). # 
compared to the saline group; * compared to the carrageenan group.  
 
3.5. Antiedematogenic activity of EEGP and aqueous fraction on paw edema  
 We verified that EEGP and aqueous fraction on paw edema is induced by 
carrageenan. According to the results, we found that EEGP showed antiedematogenic 
activity in inhibiting the paw edema (Table 1), and we observed an inhibition of 57, 60, 62, 
and 62 % for doses of 1, 3, 10, and 30 mg/kg (3 h), and 66 % (4 and 5 h after injection of 
carrageenan), for the 30 mg/kg dose.  
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Table 1. EEGP effect on the paw edema induced by carrageenan on mice 
 
The data are expressed by mean ± SEM, n = 6. Symbols indicate statistical difference (p <0.05, Tukey test). * 
compared to the carrageenan group. 
 
According to the results presented by the aqueous fraction (Table 2), it was 
possible to observe a reduction of edema only for the dose of 30 mg/kg (3 and 4 h after 
injection of carrageenan), and we found an inhibition of 56 and 49 %, respectively.  
 
Table 2. Aqueous fraction effect on the paw edema induced by carrageenan on mice 
 
 
The data are expressed by mean ± SEM, n = 6. Symbols indicate statistical difference (p <0.05, Tukey test). * 
compared to the carrageenan group. 
. 
3.6. Gas chromatography with mass spectrometry  
 The EEGP analysis by GC/MS is presented in Table 3. Only substances that 
showed a percentage of relative area greater than 5 % have been included. Most of the 
substances were not identified based on the standards utilized and on the library 
information equipment and, therefore, we did not find any flavonoid or phenolic acid 
commonly present in samples of propolis of Apis mellifera. It can be observed that 
Treatment (mg/kg) Time (h) after injection of carrageenan 
 1 2 3 4 5 
Carrageenan 0.06 ± 0.01 0.08 ± 0.01 0.13 ± 0.02 0.16 ± 0.01 0.15 ± 0.01 
      
Indomethacin 10 mg/kg 0.04 ± 0.01 0.03 ± 0.01 0.03 ± 0.01* 0.05 ± 0.02* 0.06 ± 0.02* 
      
EEGP 1 mg/kg 0.04 ± 0.01 0.05 ± 0.02 0.06 ± 0.02* 0.11 ± 0.02 0.12 ± 0.02 
EEGP 3 mg/kg 0.05 ± 0.01 0.06 ± 0.01 0.05 ± 0.01* 0.12 ± 0.01 0.15 ± 0.01 
EEGP 10 mg/kg 0.05 ± 0.01 0.05 ± 0.01 0.05 ± 0.02* 0.12 ± 0.01 0.13 ± 0.01 
EEGP 30 mg/kg 0.05 ± 0.01 0.05 ± 0.01 0.05 ± 0.01* 0.06 ± 0.01* 0.05 ± 0.02* 
Treatment (mg/kg) Time (h) after injection of carrageenan 
 1 2 3 4 5 
Carrageenan 0.08 ± 0.01 0.10 ± 0.02 0.13 ± 0.01 0.16 ± 0.02 0.15 ± 0.01 
 
Indomethacin 10 mg/kg 
 
 
0.07 ± 0.01 
 
0.06 ± 0.01 
 
0.07 ± 0.00* 
 
0.08 ± 0.01* 
 
0.06 ± 0.02* 
Aqueous fraction 1 mg/kg 0.10 ± 0.01 0.11 ± 0.01 0.11 ± 0.01 0.14 ± 0.01 0.13 ± 0.01 
Aqueous fraction 3 mg/kg 0.08 ± 0.01 0.09 ± 0.02 0.09 ± 0.01 0.13 ± 0.01 0.13 ± 0.01 
Aqueous fraction 10 mg/kg 0.06 ± 0.01 0.08 ± 0.01 0.08 ± 0.02 0.11 ± 0.02 0.11 ± 0.01 
Aqueous fraction 30 mg/kg 0.06 ± 0.01 0.05 ± 0.02 0.06 ± 0.02* 0.08 ± 0.03* 0.09 ± 0.02 
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compounds 5 and 6 presented themselves as the majority, with a percentage of 19.17 and 
29.15 %, respectively. Compounds 6 and 7, despite showing similarity in terms of M
+
 (m/z 
623), as well as retention time, have distinct ion fragmentation. Regarding the aqueous 
fraction, we did not detect any peak higher than the baseline noise of the mass detector. 
 
Table 3. Retention time, % of relative area, and major ions present in the mass spectra of 
compounds silanized of the ethanolic extract of geopropolis (EEGP) of Melipona 
scutellaris by GC/MS. 
 
 
RT
a 
-
 
Retention time; Symbols (-) not detected; + <0.1 % of relative area.  
 
3.7. High performance liquid chromatography reverse phase 
According to the chromatograms obtained by high performance liquid 
chromatography reverse phase (HPLC-FR) of EEGP and aqueous fraction (Figure 5A and 
B), utilizing the same gradient elution, we observed the existence of different chemical 
profiles. In the chromatogram of EEGP, we can see a great predominance of nonpolar 
compounds, with retention times over 70 min, which is superior to the retention time of all 
standards of flavonoids utilized. In the chromatogram of the aqueous fraction, we observed 
the predominance of a single peak and intensity greater than in EEGP. However, when the 
aqueous fraction was analyzed utilizing an optimized mobile phase for polar compounds 
(Figure 5C), we could verify the existence of two major compounds that are not compatible 
with any of the standards utilized, therefore demonstrating that they are highly polar 
molecules of low molecular weight. 
Compound Name Rt
a
 (min) Relative area (%) Ion (m/z, abundance in parentheses)
1  2-propensaeure 3-phenyl-trimethylsilylester  17.84 8.91 220 (31), 205 (100), 161 (90), 145 (33), 131 (88), 103 (60), 77 (49)
2 1,2-benzenedicarboxylic acid 36.60 + 167 (33), 149 (100), 57 (40)
3 - 43.79 6.88 591 (11), 589 (48), 501 (100), 459 (25), 445 (28), 73 (90), 57 (13)  
4 - 46.94 5.79 495 (100), 459 (60), 417 (21), 73 (40), 57 (21)
5 - 47.29 19.17 548 (39), 533 (34), 479 (17), 389 (45), 73 (100), 45 (11)
6 - 47.71 29.15 623 (66), 536 (20), 535 (52), 73 (100)
7 - 47.91 6.93 623 (1), 551 (48), 533 (17), 461 (32) 407 (86), 73 (100)
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Figure 5. Chromatograms obtained by HPLC-RP of the ethanolic extract of geopropolis (EEGP-A) and 
aqueous fraction (B-C). 
 
4. Discussion 
 
The development of new anti-inflammatory drugs that interfere with the traffic 
of neutrophils during the inflammatory process is a great therapeutic interest. This fact is 
understandable due to the seminal role of neutrophils in the development of various 
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inflammatory diseases, as the rheumatoid arthritis, chronic obstructive pulmonary disease 
and periodontal disease [30-32]. 
In this context, it is recognized that most new drugs discovered in recent 
decades had natural products as the main source [12]. The present study demonstrated that 
the ethanolic extract of geopropolis (EEGP) and its aqueous fraction decreased leukocyte 
interaction (rolling and adhesion) with endothelial cells, as well as neutrophil migration 
into the peritoneal cavity of mice subjected to intraperitoneal injection of carrageenan 
through suppression of adhesion molecules ICAM-1, which is an NO pathway-dependent 
activity. 
The inflammatory process is a set of events arising from the participation of 
various chemical mediators that promote vascular events, edema, and the recruitment of 
leukocytes [7]. NO plays different physiological functions in the body, among them as a 
regulator of vascular tone and modulator of leukocytes adhesion in the blood capillaries and 
microcapillaries. Its production involves the participation a family of enzymes known NO 
synthases (NOS). Among them, the inducible NOS (iNOS) is induced only in the 
inflammatory process [33,10,11]. 
Recent studies have shown that the inhibitory effect of NO (via iNOS 
activation) on migration of neutrophils in the inflammatory process is dependent on the 
activation of enzyme soluble guanylate cyclase (sGC). This inhibition of neutrophil 
migration by sGC mediated, generates increased levels of guanosine 3′5′-cyclic 
monophosphate (cGMP), and consequently inhibition of the adhesion molecules ICAM-1 
[10-11].  
The present study demonstrated that treatment with specific antagonists of 
iNOS, or the soluble guanylate cyclase suppressed the inhibition of neutrophil migration by 
EEGP and its aqueous fraction. These results suggest, therefore, that the inhibitory effect of 
EEGP and the aqueous fraction on the neutrophils migration by NO pathway is related to 
increased levels of NO (via iNOS activation), which can be observed by the increase in 
nitrite levels and consequent activation of the sGC/cGMP pathway, thus leading to the 
suppression of adhesion molecules ICAM-1. 
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As the edema is one of the key events of the inflammatory response, we also 
evaluated the effectiveness of EEGP and the aqueous fraction on the paw edema induced by 
carrageenan. The first phase (0-2.5 h) of paw edema induced by carrageenan is associated 
with increase in the histamine, serotonin, and kinins chemical mediators, and these are 
related with the increase in vascular permeability, besides the increased production of the 
IL-1β and TNF-α cytokines [34,35]. In the second phase (3-4 h) occurs the production of 
mediators derived from the inducible cyclooxygenase enzyme, such as prostaglandins, and 
this second phase is sensitive to anti-inflammatory cyclooxygenase inhibitors [34,35]. 
According to the results presented, EEGP and its aqueous fraction decreased the paw 
edema induced by carrageenan, where this activity was observed only in the second phase 
(3-4 h) of the experiment. These results therefore suggest that the activity of EEGP and the 
aqueous fraction may be related to the inhibition of prostaglandin formation. 
 In relation to chemical analysis by GC/MS, we observed the presence of 
chemical compounds, including two identified. Regarding the aqueous fraction, no 
compound has been found by the library of the equipment, which may be due to the 
limitations of the technique, for example, the chemical derivatization made, where resulting 
compounds may have been highly unstable and decayed. On the other hand, when the 
aqueous fraction analysis was performed by HPLC with mobile phase optimized for polar 
compounds, two distinct chemical substances could be identified, which shows the highly 
polar characteristic of bioactive chemical compounds. No flavonoid or phenolic acid was 
found in EEGP and the aqueous fraction. These phenolic are a class of chemicals reported 
in the literature as responsible for most of the biological activity of propolis from Apis 
mellifera [36,28], thus suggesting a different chemical profile of the Melipona scutellaris 
geopropolis, as evidenced in EEGP and its aqueous fraction. These chemical profile data 
therefore suggest the presence of chemical compounds that are not reported in the literature 
as to their pharmacological activities (especially the anti-inflammatory one) and that 
deserve special attention due to its promising mechanism of action.  
Therefore, we conclude that the EEGP and its aqueous fraction decreased 
migration of neutrophils in the inflammatory process, and this is dependent on nitric oxide 
pathway. Thus, due to their distinct chemical profile and mechanism of action promising, 
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further studies are necessary for the isolation and identification of bioactive compounds 
present in the aqueous fraction, in which may enable the development of new effective anti-
inflammatory drugs for the treatment of diseases inflammatory. 
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Scheme 1: Mechanism of action of the EEGP and aqueous fraction on inhibition of 
neutrophil migration during the inflammatory process by nitric oxide pathway   
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Abstract 
 
Ethnopharmacological relevance: Propolis has been widely used by folk medicine for 
centuries. It is described in the literature as possessing various biological activities, 
however, most of these reports refer to the propolis of Apis mellifera. The geopropolis 
collected by stingless bees (in extinction process) is a kind of neglected propolis by the 
science maybe because it does not have economic aggregated value; however it is widely 
used by the poor communities in Brazil especially in the Northeast region, and whose 
pharmacological activity needs to be studied. 
Objective: The aim of this study was to evaluate the antinociceptive activity of Melipona 
scutellaris geopropolis (stingles bees) using different models of nociception. 
Material, methods and results: The ethanolic extract of geopropolis (EEGP) from 
Melipona scutellaris, as well as the hexane and aqueous fractions decreased the numbers of 
writhes in the acetic acid induced constriction test. In the formalin test, the EEGP and the 
aqueous fraction clearly demonstrated antinociceptive activity in both neurogenic and 
inflammatory phases, while the hexane fraction suppressed only the neurogenic phase. The 
treatment with EEGP and aqueous fraction reduced mechanical inflammatory 
hypernociception induced by carrageenan and also reduced the levels of IL-1 β and TNF-α. 
The chemical analyses demonstrated the presence of phenolic compounds and absence of 
flavonoids. 
Conclusion: The EEGP and its hexane and aqueous fractions showed antinociceptive 
activity. The EEGP and aqueous fraction demonstrated activity in the mechanical 
inflammatory hypernociception induced by carrageenan model, and this effect is mediated 
by inhibition of IL-1β and TNF-α. These data indicate that geopropolis is a natural source 
of bioactive substances with promising antinociceptive activities.  
 
Keywords: Geopropolis, Melipona scutellaris, bioactive fractions, antinociceptive, 
cytokines, pain. 
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1. Introduction 
 
In recent decades, several studies have shown that analgesics are like one of the 
most studied classes of drugs in the world. This fact is understandable due to the high 
consumption of these drugs worldwide, although it may present some adverse effects and 
low therapeutic efficacy. Thus, the effort to develop new drugs have been focus in 
screenings of extracts from natural sources and historically led the discovery of many 
clinically important drugs in the current therapy (Verri jr et al., 2006; Newman et al., 2003). 
Propolis is a resin product collected by honey bees from several parts of plants 
(Silva et al., 2008). For centuries propolis has long been used as a popular folk medicine, 
due to its biological and pharmaceutical properties that include antiviral, anti-inflammatory, 
analgesic, anticaries, antibacterial, antioxidant and anticancer activities (Kujumgiev et al., 
1999; Paulino et al., 2003; Hu et al., 2005; Koo et al., 1999; 2000; 2002; Scazzocchio et al., 
2006; Kumazawa et al., 2007; Silva et al., 2008; Awale et al., 2008). Although a multitude 
of studies about propolis have been published previously, most of them are from Apis 
mellifera. In contrast, reports about propolis from other species of bees have been studied 
sparse. 
The bees species Melipona scutellaris, which belongs to Meliponini tribe 
(stingless bees in the process of extinction), produces a variety of propolis popularly known 
as geopropolis. This geopropolis consists of a mixture of resin, wax and soil, providing 
distinctive physico-chemical characteristics (Nates-Parra, 2001; Barth, 2006), however, 
very little is known about its chemical composition and biological activity.  
Among the few reports, Velikova et al. (2000) analyzed 21 samples of Brazilian 
geopropolis from twelve different species of stingless bees, and observed the presence of 
compounds such as di-and triterpenes and gallic acid. The same samples showed activity 
against Staphylococcus aureus, and cytotoxic activity. Another study reported that samples 
of Melipona fasciculata geopropolis from Maranhão State showed activity against 
Streptococcus mutans (Liberio et al., 2011). Bankova et al. (2000) identified more than fifty 
compounds, mainly phenolic and terpene in Brazilian geopropolis from Melipona 
compressipes, Melipona quadrifasciata anthidioides and Tetragona clavipes. Previous 
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investigations from our laboratory have found that geopropolis from Melipona scutellaris 
has antimicrobial action against Staphylococcus aureus and antioxidant activity. These 
findings suggested that Melipona scutellaris geopropolis is highly bioactive deserving 
further studies to identify other possible biological activities, as well as to elucidate its 
chemical composition, which would ultimately strengthen its popular use. 
Thus, the aim of this study was to evaluate the antinociceptive activity of 
ethanolic extract of geopropolis (EEGP) of Melipona scutellaris and fractions using the 
chemical models of abdominal constrictions induced by acetic acid and formalin test. 
Moreover to evaluate the activity of the EEGP and bioactive fractions in mechanical of 
inflammatory hypernociception model and the production of IL-1β and TNF-α. 
Additionally we have analyzed the chemical composition of EEGP and bioactive fractions. 
 
2. Material and Methods  
 
2.1. Geopropolis samples and fractionation 
The geopropolis samples were collected from the inner parts of the beehives, 
more specifically in the space between the cover and supers of hives. Geopropolis was 
collected between June and July of 2010 in the seaside region, municipality of “Entre Rios” 
(SL 11°56'31'' and WL 38º05'04''), state of Bahia, Northeast of Brazil. The geopropolis 
(100 g) was extracted with absolute ethanol (w/v) of proportion (1/7), at 70 ºC, for 30 min, 
and then filtered to obtain the EEGP. The EEGP was further fractioned using a liquid–
liquid extraction technique with hexane, chloroform, and ethyl acetate solvents. At the end 
of three partitions, it was obtained a residue called „aqueous fraction‟. The fractions 
obtained were monitored by thin layer chromatography (TLC) using the anisaldehyde 
reagent (4-methoxy-benzaldehyde, acetic acid, sulphuric acid/1.0:48.5:0.5) and followed by 
incubation at 100 ºC for 5 min. Fluorescent substances were visualized under UV light at 
the wavelengths of 254 and 366 nm (Tanaka et al., 2005). The EEGP and its hexane, 
chloroform, ethyl acetate, and aqueous fractions were concentrated in a rotaevaporator at 40 
ºC to obtain a yield of 4.33 (w/w), 1.98 (w/w), 0.23 (w/w), 0.87 (w/w), and 1.25 (w/w), 
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respectively. The EEGP and fractions were dissolved in DMSO, PBS 1 mM 1:99 for 
intraperitoneal (i.p.) administration. 
 
2.2. Animals 
Male SPF (specific-pathogen free) Balb/c mice weighing 20-25 g were housed 
in temperature (22-25 °C), 12 h light/ 12 h dark and humidity (40-60 %) with access to 
water and food ad libitum. Experiments reported in this study were carried out in 
accordance with current guidelines for the care of laboratory animals and the ethical 
guidelines for investigation of experimental pain in conscious animals (Zimmermann, 
1983). All efforts were made to minimize the number of animals used and their suffering. 
The procedures described were reviewed and was approved by the local animal Ethics 
committee (CEUA Unicamp process number 2037-1). 
 
2.3. Drugs and reagents 
The drugs were purchased from Sigma
® 
Chemical Co., St. Louis, MO, USA
 
(Carrageenan), MP Biomedicals
®
 (Indomethacin), Merck
®
 (Formaldehyde, Acetic acid and 
organic solvents) and Cristalia
®
 (Morphine and Naloxone). 
 
2.4. Biological protocols 
 
2.4.1. Evaluation of activity of EEGP and fractions on abdominal constriction response 
caused by acetic acid 
The abdominal constriction (writhes) were induced by i.p. injection of acetic 
acid (1.2 %, v/v) and carried out according to the procedure described previously (Koster et 
al., 1959; Collier et al., 1968). Mice were treated with EEGP, chloroform, ethyl acetate, 
aqueous (1, 3, 10 and 30 mg/kg, i.p.) or hexane fractions (0.1, 0.3, 1 and 3 mg/kg, i.p.) 30 
min before irritant injection. Indomethacin (10 mg/kg, i.p.) was used as positive control and 
the vehicle was used as the negative one. After the challenge, the mice were individually 
placed in a glass cylinder of 22 cm diameter. The total numbers of writhes, which consist in 
the constriction of the flank muscles associated with inward movements of the hind limb or 
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with whole body stretching, were counted cumulatively a period of 20 min. The 
antinociceptive activity was determined as the difference in number of writhes between 
control group and each treated group. 
 
2.4.2. Evaluation of activity of EEGP and bioactive fractions on formalin-induced 
nociception 
The method used in the present study was similar to that described previously 
by Corrêa & Calixto, (1993). The mice were treated with EEGP, aqueous (1, 3, 10 and 30 
mg/kg, i.p.) or hexane fractions (0.1, 0.3, 1 and 3 mg/kg, i.p.) 30 min before injection under 
the surface of the right hind paw of 25 µL 2.5% formalin (0.92% formaldehyde) in saline. 
Indomethacin (10 mg/kg, i.p.) and morphine (10 mg/kg, i.p.) was used as the positive 
control and vehicle was used as the negative one. Animals were observed from 0–5 min 
(neurogenic phase) and 15–30 min (inflammatory phase) and the time spent licking the 
injected paw was recorded with a chronometer and considered as indicative of nociception. 
 
2.4.3. Evaluation of activity of EEGP and bioactive fractions on carrageenan-induced 
inflammatory hypernociception 
Mechanical hypernociception was tested in mice as previously reported Cunha 
et al. (2004). The mice were treated with EEGP, aqueous (1, 3, 10 and 30 mg/kg, i.p.) or 
hexane fractions (0.1, 0.3, 1 and 3 mg/kg, i.p.) 30 min before injection under the surface of 
the left hindpaw of 25 µL carrageenan (100 µg/paw). Indomethacin (10 mg/kg, i.p.) was 
used as the positive control and vehicle was used as the negative one. After the challenge, 
in a quiet room, mice were placed in acrylic cages (12×10×17 cm) with wire grid floors 
(0.5 cm
2
), 15–30 min before the start of testing. The test consisted of evoking a hind paw 
flexion reflex with a hand-held force transducer (Insight Scientific Equipments, SP, Brazil) 
adapted with a 0.5 mm
2
 polypropylene tip. The investigator was trained to apply the tip 
perpendicularly to the central area of the hind paw with a gradual increase in pressure. The 
end point was characterized by the removal of the paw followed by clear flinching 
movements. After the paw withdrawal, the intensity of the pressure was recorded 
automatically. The value for the response was an averaging of three measurements. The 
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animals were tested before and after treatments. The results are expressed by delta (Δ) 
withdrawal threshold (in g) calculated by subtracting the zero-time mean measurements 
(before carrageenan injection) from the mean measurements 3 h after stimulus (after 
carrageenan injection). 
 
2.4.3.1. Cytokine assays 
Based on previous test (2.4.3) the EEGP and aqueous fraction were selected for 
the quantification of proinflammatory cytokine. The mice were treated with EEGP or 
aqueous fraction (30 mg/kg, i.p.) 30 min before injection under the surface of the left hind 
paw of 25 µL carrageenan (100 µg/paw). Vehicle was used as the negative control. After 3 
h, animals were killed, the plantar skin tissues were removed from the injected and control 
paws (saline). The samples were homogenized in 500 μl of the appropriate buffer 
containing protease inhibitors (Sigma
®
). Levels of TNF-α and IL-1β, were determined by 
ELISA using protocols supplied by the manufacturers (Peprotech
®
 Inc.) from both 
experiments. The results are expressed as picograms. 
 
2.4.4. Evaluation of activity of EEGP and bioactive fractions on locomotor activity 
The open-field test was used to exclude the possibility that the antinociceptive 
action of EEGP, hexane and aqueous fractions could be resultant from non-specific 
disturbances in the locomotor activity of the animals. The ambulatory behavior was 
assessed in an open-field test as described previously Rodrigues et al. (2002) with few 
changes. The apparatus consisted of a plastic box measuring 45 x 45 x 20 cm, with the floor 
divided into 9 equal squares (15 x 15 cm). The number of squares crossed with all paws 
(crossing) was counted in a 6-min session. Mice were treated with EEGP (1, 3, 10 and 30 
mg/kg, i.p.), hexane (1 and 3 mg/kg) and aqueous (10 and 30 mg/kg) fractions or vehicle 30 
min. The doses established in this test showed effect in the previous tests. 
 
2.5. Chemical composition analysis of EEGP and bioactive fractions 
 
2.5.1. Total polyphenol and flavonoid contents 
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Total polyphenol content in EEGP, hexane and aqueous fractions was 
determined by the Folin–Ciocalteau colorimetric method (Singleton et al., 1999). EEGP or 
fractions (0.5 ml) were mixed with 2.5 ml of the Folin–Ciocalteau reagent (1:10) and 2.0 ml 
of 4% Na2CO3. Absorbance was measured at 740 nm after 2h incubation at room 
temperature, in the dark. EEGP and its fraction hexane and aqueous were evaluated at the 
final concentration of 90 µg/ml. Total polyphenol contents were expressed as mg/g (gallic 
acid equivalents).  
Total flavonoid contents in the EEGP, hexane and aqueous fractions were 
determined using a method described by Park et al. (1995), with minor modifications. For 
this, 0.5 ml of EEGP, hexane fraction, and aqueous solution, 4.3 ml of 80% ethanol, 0.1 ml 
of 10% Al(NO3)3 and 0.1 ml of 1M potassium acetate was added. After 40 min at room 
temperature, the absorbance was measured at 415 nm. EEGP, hexane fraction and aqueous 
were evaluated at the final concentration of 2 mg/ml. Total flavonoid contents were 
calculated as quercetin (mg/g) from a calibration curve. 
 
2.6. Statistical analysis 
Data were expressed as mean ± S.E.M., statistical comparisons between groups 
were made using analyses of variance (ANOVA) followed by Tukey test. Significance was 
accepted when the p value was ≤0.05. 
 
3. Results 
 
3.1. EEGP, hexane and aqueous fractions decreased the number of abdominal 
constrictions induced by acetic acid  
The test of abdominal constrictions induced by acetic acid was initially used to 
evaluate the antinociceptive activity of the EEGP and their fractions. The results showed in 
Figure 1A demonstrate that the EEGP (3, 10 and 30 mg/kg), produced dose-related 
inhibition of abdominal constrictions induced by acetic acid in mice (p<0.05), with 
inhibitions of 31, 56 and 75 % respectively. The hexane fraction was able to inhibit the 
number of writhes (p<0.05) in 49 and 70 % at doses of 1 and 3 mg/kg, respectively (Figure 
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1B), and the aqueous fraction inhibited (p<0.05) in 54 and 81 % at doses of 10 and 30 mg/ 
kg, respectively (Figura 1E). On the other hand, the chloroformic fraction (Figure 1C) and 
the ethyl acetate fraction (Figure 1D), did not show any inhibition (p>0.05). Then the 
hexane and the aqueous fractions were selected like the bioactive fractions from EEGP.  
 
 
Figure 1. Effect of i.p. injection of ethanolic extract of geopropolis (EEGP) and fraction on abdominal 
constriction induced by acetic acid in mice. Control (C) treated with vehicle, indomethacin 10 mg/kg (indo), 
EEGP (A), fractions: hexane (HF, B), choroformic (CF, C), ethyl acetate (EAF, D) and aqueous (AF, E). The 
data are expressed by mean ± SEM, n = 6. Symbol indicate statistical difference (p <0.05, Tukey test). * 
p<0.05 compared to control group. 
 
3.2. EEGP, hexane and aqueous fractions decreased nociception induced by formalin   
The results in Figure 2A and B show that the EEGP caused significant 
inhibition (p<0.05) of both neurogenic (first phase: 0–5 min) and inflammatory (second 
phase: 15–30 min) phases of the formalin-induced licking. The calculated inhibition values 
for these effects were 51 and 50 % for the doses of 10 and 30 mg/kg, respectively in the 
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first phase. In the second phase the EEGP inhibited the response in 68, 52, 51 e 56 % for 
the doses of 1, 3, 10 e 30 mg/kg, respectively. The hexane fraction showed activity only in 
the first phase (p<0.05), with an inhibition of 65 % at the dose of 1 mg/kg (Figure 2C). The 
aqueous fraction caused significant inhibition of both phases of the formalin-induced 
licking (p<0.05), with 59 % at the dose of 10 mg/kg (phase 1), and 70 and 82% at the doses 
of 10 and 30 mg/kg (phase 2), respectively (Figure 2E and F). 
 
Figure 2. Effect of i.p. injection of ethanolic extract of geopropolis (EEGP) and bioactive fraction on 
formalin-induced nociception in mice. Control (C) treated with vehicle, indomethacin 10 mg/kg (indo), 
morphine 10mg/kg (morph), EEGP (A-B), hexane fraction (HF, C-D) and aqueous fraction (AF, E-F). The 
data are expressed by mean ± SEM, n = 6. Symbol indicate statistical difference (p <0.05, Tukey test). * 
p<0.05 compared to control group. 
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3.3. EEGP and aqueous fractions decreased mechanical inflammatory hypernociception 
induced by carrageenan  
The effects of EEGP on hypernociception induced by carrageenan are shown in 
Figure 3A. EEGP at the tested doses of 10 and 30 mg/kg showed an inhibition of 43 and 
70%, respectively (p<0.05). The aqueous fraction showed an inhibition (p<0.05) of 66% 
only at 30 mg/kg (Figure 3C). On the other hand, the hexane fraction was not effective even 
at the highest dose tested (Figure 3B, p>0.05). 
 
Figure 3. Effect of i.p. injection of ethanolic extract of geopropolis (EEGP) and bioactive fraction on 
mechanical inflammatory hypernociception induced by carrageenan in mice. Control (C) treated with vehicle, 
indomethacin 10 mg/kg (indo), EEGP (A), hexane fraction (HF, B) and aqueous fraction (AF, C). The data 
are expressed by mean ± SEM, n = 6. Symbol indicate statistical difference (p <0.05, Tukey test). * p<0.05 
compared to control group. 
 
3.3.1. Cytokine assay 
The administration of EEGP and its aqueous fraction at a dose of 30 mg/kg, 
significantly reduced (p<0.05) the levels of IL-1β (77 and 89%, respectively) and TNF-α 
(41 and 48%, respectively), in mice subjected to subplantar injection of carrageenan (Figure 
4A and B).  
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Figure 4. Quantification of IL-1 β (A) and TNF-α (B) in the hind paw tissue of mice previously treated with 
vehicle (saline and carrageenan), ethanolic extract of geopropolis (EEGP) and aqueous fraction (AF) at a dose 
of 30 mg/kg 30 min before the intraplantar injection of carrageenan. The data are expressed by mean ± SEM, 
n = 5. Symbols indicate statistical difference (p <0.05, Tukey test). # p<0.05 compared to saline group; * 
p<0.05 compared to carrageenan group. 
 
3.4. EEGP and bioactive fractions did not changed the locomotor activity of mice  
The administration of EEGP, hexane or aqueous fractions by the i.p. route have 
not changed the locomotor activity of animals during the 6 min of observation compared 
with animals that received vehicle (p>0.05). The means ± SEM. crossed squared were 39 ± 
4 (control group), 45 ± 8; 23 ± 2; 37 ± 11 and 42 ± 11 for the EEGP (at 1, 3, 10 and 30 
mg/kg, respectively), 31 ± 5 and 46 ± 19 for the hexane fraction (at 1 and 3 mg/kg, 
respectively) and 22 ± 9 and 23 ± 7 for the aqueous fraction (at 10 and 30 mg/kg, 
respectively). 
 
3.5. Total polyphenol and flavonoid contents of EEGP and bioactive fractions 
The mean ± SD of the total phenols was estimated as 255 ± 3.8, 76 ± 1.5 e 277 
± 1.3 w/w % gallic acid equivalents for the EEGP, hexane and aqueous fractions, 
respectively (Table 1). It was not observed the presence of flavonoids in any sample 
evaluated. 
 
  
40 
 
Table 1. Quantification of total phenols in EEGP, hexanic and aqueous fractions by Folin-
Ciocalteau method. 
 
Sample mgGAE/g sample 
EEGP 255± 3.8 
Hexanic fraction 76± 1.5 
Aqueous fraction 277± 1.3 
 
Mean ± SD, n=03 
Total phenolic compounds expressed in mg gallic acid equivalent (GAE)/g of sample) 
 
 
4. Discussion 
 
The aim of this study was evaluate the antinociceptive activity of Melipona 
scutellaris from geopropolis in different models of nociception, as well as the mechanism 
of action related.  
The ability of the EEGP as well as the hexane and aqueous fractions to 
attenuate the abdominal constrictions induced by acetic acid in mice suggests that they 
possess antinociceptive activity. The acetic acid induced constrictions test is described as a 
typical model of inflammatory pain, has long been used as a screening tool for the 
assessment the analgesic properties of new drugs (Le Bars et al., 2001). The nociceptive 
response produced by constrictions test is due to the participation of several mediators such 
as prostaglandins, proinflammatory cytokines such as interleukin-1β, interleukin 8, TNF-α, 
sympathomimetic amines, acetylcholine, substance P, among others (Kusuhara et al., 1997; 
Ribeiro et al., 2000; Duarte et al., 1988; Le Bars et al., 2001). However, the test of 
abdominal constrictions has low specificity, since several compounds, such as 
antihistamines, neuroleptics and adrenergic blockers may also inhibit constrictions (Le Bars 
et al., 2001). Thus we used the formalin test, a chemical model of nociception, which 
provides a more specific response compared with the model of abdominal constrictions 
induced by acetic acid (Tjolsen et al., 1992).   
The injection of formalin produces a biphasic behavioral response in which the 
first phase (0 to 5 min) is characterized by the occurrence of neurogenic pain by direct 
stimulation of nociceptive afferent endings and the second phase (15 to 30 min) is 
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characterized by peripheral inflammation and involves a period of sensitization during 
which inflammatory phenomena occur (Tjolsen et al., 1992). In this study, the EEGP and 
its aqueous fraction showed antinociceptive activity in both phases neurogenic and 
inflammatory, while the hexane fraction showed activity only in neurogenic phase. 
The effect of EEGP and its bioactive fractions was also evaluated in a model of 
mechanical inflammatory hypernociception induced by carrageenan in mice and the 
production of IL-1β and TNF-α. Carrageenan is an inflammatory agent that is largely used 
as pharmacological tool for investigating inflammatory hypernociception in rats and mice. 
When injected intraplantarly of animal's hind paw, it induces an inflammatory process 
associated with hypernociception (Cunha et al., 2004). Tissue injury originated after the 
injection of carrageenan involves the release of different chemical mediators such as PGE2, 
mast cells products histamine and serotonin, neuropeptides, and proinflamatory cytokines 
among others (Cunha et al., 1992; Ferreira et al., 1993). Cytokines like IL-1β and TNF-α 
play a crucial role in the release of prostanoids. This process occurs in the following 
sequence: TNF-α → IL-1β → prostanoids which sensitize nociceptors (Cunha et al., 2005). 
The release of proinflammatory cytokines IL-1β and TNF-α are also is directly related to 
the migration of neutrophils in the inflammatory process, with induced rolling and adhesion 
of neutrophils in the vascular endothelium, and transmigration into the inflammatory site 
(Hogg & Walker, 1995).  When neutrophils are present in inflammatory focus they release 
hypernociceptive mediators such as prostaglandins (Cunha et al., 2008). In the present 
study, the administration of EEGP and aqueous fraction reduced the inflammatory 
hypernociception could be related with the inhibition of IL-1β and TNF- α cytokines and 
consequent inhibition the release of prostanoids and also the interaction neutrophils and 
endothelial cells. In the present study, we observed that the hexane fraction did not decrease 
mechanical inflammatory hypernociception, suggesting, therefore, another course of action 
independent of the inflammatory process. Important, this result did not affect the locomotor 
activity during the open field test. The animals treated with the EEGP and the bioactive 
fractions did not cause any significant change in the ambulation of mice, excluding non-
specific disturbance in the locomotor activity.  
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This study was also carried out a phytochemical analysis of EEGP and its 
bioactive fractions, by quantification of total phenolics and flavonoids. The concentrations 
of phenolic compounds in EEGP were higher than those found in propolis type 12 Apis 
mellifera (Castro et al., 2007), which is the single most studied propolis worldwide. 
Regarding the bioactive fractions, the presence of phenolic compounds in both fractions 
(hexane and aqueous) demonstrates the presence of these compounds of different polarities. 
In addition, it was observed the absence of flavonoids in EEGP and its bioactive fractions, 
which is a very common chemical class in Apis mellifera propolis (Kumazawa et al., 2004, 
Alencar et al., 2007). The absence of flavonoids in geopropolis is comparable with a unique 
Brazilian propolis from Apis mellifera (Duarte et al., 2003). This particular Apis mellifera 
propolis was also collected from the Atlantic forest in the state of Bahia (Northeastern 
Brazil), which is not far away (about a 70 km radius) from where the geopropolis was 
collected for this study. Since the geographical location and vegetation are related with 
propolis chemical composition (Castro et al., 2007) it appears reasonable to suggest that the 
vegetal resin originating the propolis type 6 could have some similarity to that of the 
geopropolis. Additionally, propolis type 6 has a group of polyprenylated benzophenones 
whose biological activity was assigned to the substance hiperibone A, a novel naturally 
occurring biomolecule (Castro et al., 2009). These observations suggest that the 
geopropolis from Melipona scutellaris may have an unusual chemical composition devoid 
of significant amounts of flavonoids, and thereby warrants further characterization of its 
chemical composition and the isolation/identification of the bioactive compounds. 
Therefore we conclude that the EEGP and its hexane and aqueous fractions 
showed antinociceptive activity. The EEGP and aqueous fraction demonstrated activity in 
the mechanical inflammatory hypernociception induced by carrageenan model, and this 
effect is mediated by inhibition of IL-1β and TNF-α. The chemical composition showed the 
significant presence of phenolic compounds and absence of flavonoids, thus suggesting that 
more studies should be conducted for the identification and isolation of bioactive 
compounds. 
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Scheme 2: Mechanism of action of EEGP and aqueous fraction of the decrease in 
mechanical inflammatory hypernociception by inhibiting the production of cytokine IL-1β 
and TNF-α.  
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CONCLUSÃO 
 
Portanto conclui-se: 
 
 O EEGP e sua fração aquosa inibiram a migração de neutrófilos no processo 
inflamatório, sendo está atividade dependente da via do NO; 
 
 O EEGP e suas frações hexânica e aquosa apresentaram atividade antinociceptiva. 
Foi constatada atividade para o EEGP e fração aquosa na hipernocicepção 
inflamatória mecânica induzida por carragenina, sendo está atividade mediada pela 
inibição das citocinas IL-1β e TNF-α; 
 
 Foi verificada uma característica química diferenciada das frações bioativas, quando 
comparada à maioria das outras variedades de própolis amplamente estudadas pela 
comunidade científica, sugerindo, portanto, que mais estudos sejam conduzidos para 
o isolamento e identificação dos compostos biologicamente ativos presentes nas 
frações bioativas. 
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ANEXO 3: Prêmio concedido pela Sociedade Brasileira de Pesquisa Odontológica 
(SBPqO). 
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ANEXO 4: Comprovante de submissão do artigo referente ao Capítulo 1 (“Bioactive 
fraction of geopropolis decreases neutrophils migration in inflammatory process: 
involvement of nitric oxide pathway”). 
 
 
 
 
 
 
 
